GenMark Diagnostics Inc (GNMK):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:GenMark Diagnostics Inc (GNMK) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7886
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test, and others. GenMark develops products used in treatment of CNS infections, GI infections, genetic conditions, hepatitis, respiratory infections and sepsis, among others. The company provides educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity, among others. It operates in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

GenMark Diagnostics Inc (GNMK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenMark Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenMark Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GenMark Diagnostics Inc, Medical Equipment, Deal Details 10
Partnerships 10
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 10
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 11
Equity Offering 12
GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 12
GenMark Diagnostics Completes Public Offering Of Shares For US$86.3 Million 14
GenMark Diagnostics Completes Public Offering Of Shares For US$48 Million 16
GenMark Diagnostics Inc – Key Competitors 18
GenMark Diagnostics Inc – Key Employees 19
GenMark Diagnostics Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Jul 30, 2018: GenMark Diagnostics Reports Second Quarter 2018 Results 21
May 01, 2018: GenMark Diagnostics Announces First Quarter 2018 Financial Results 22
Feb 27, 2018: GenMark Diagnostics Reports Fourth Quarter and Full Year 2017 Results 23
Nov 02, 2017: GenMark Diagnostics Reports Third Quarter 2017 Results 24
Aug 01, 2017: GenMark Reports Second Quarter 2017 Results 25
May 02, 2017: GenMark Diagnostics Reports First Quarter 2017 Results 26
Feb 28, 2017: GenMark Diagnostics Reports Fourth Quarter and Full Year 2016 Results 27
Jan 10, 2017: GenMark Announces Preliminary Q4 2016 Financial Results 28
Legal and Regulatory 29
Jun 29, 2017: GenMark Achieves CE Mark for its ePlex Blood Culture Identification Gram-Positive and Gram-Negative Panels 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
GenMark Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenMark Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenMark Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 10
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 11
GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 12
GenMark Diagnostics Completes Public Offering Of Shares For US$86.3 Million 14
GenMark Diagnostics Completes Public Offering Of Shares For US$48 Million 16
GenMark Diagnostics Inc, Key Competitors 18
GenMark Diagnostics Inc, Key Employees 19

List of Figures
GenMark Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
GenMark Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GenMark Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GenMark Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[GenMark Diagnostics Inc (GNMK):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Engie S.A.:企業のM&A・事業提携・投資動向
    Engie S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Engie S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Kkr Financial Holdings Llc
    Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report Summary Kkr Financial Holdings Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Enable Injections Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enable Injections Inc (Enable Injections) is a medical device company that manufactures and develops disposable body-worn bolus injector to deliver high viscosity payloads to the subcutaneous tissue. The company develops delivery device, delivery systems, and injector systems including vial …
  • Mainstream Renewable Power Ltd-エネルギー分野:企業M&A・提携分析
    Summary Mainstream Renewable Power Ltd (Mainstream) develops, finances, constructs, and operates large-scale renewable energy plants. It develops and builds onshore and offshore wind and solar power plants. The company sells the plants to its natural owners including utilities, energy intensive corp …
  • Alps Industries Ltd.:企業の戦略・SWOT・財務分析
    Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MicroPort Scientific Corp (853):企業の財務・戦略的SWOT分析
    Summary MicroPort Scientific Corp (MicroPort) operates as a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, electronic laparoscope devices, neurova …
  • InSightec Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its servi …
  • Extreme Networks Inc (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks Inc (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • TOMS Gruppen AS:企業の戦略的SWOT分析
    TOMS Gruppen AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Xped Limited (XPE)-エネルギー分野:企業M&A・提携分析
    Summary Xped Limited (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • National Institutes of Health:企業のM&A・事業提携・投資動向
    National Institutes of Health - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Institutes of Health Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Beijing Shouhang IHW Resources Saving Technology Co Ltd (002665):電力:M&Aディール及び事業提携情報
    Summary Beijing Shouhang IHW Resources Saving Technology Co Ltd (Shouhang IHW Resources) is an electrical equipment company that offers heat generation systems. The company designs, manufactures and distributes CSP power generating system, thermal power plant air cooling system, waste heat power gen …
  • Megapharm Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Megapharm Ltd (Megapharm) is a biotechnology company which offers marketing services. It is engaged in marketing of pharmaceutical products for international companies. Megapharm markets a wide range of products in various therapeutic areas such as dermatology, gastroenterology, central nerv …
  • MDC Holdings Inc:企業の戦略・SWOT・財務情報
    MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pulsion Medical Systems SE (PUS):医療機器:M&Aディール及び事業提携情報
    Summary Pulsion Medical Systems SE (Pulsion Medical Systems), formerly Pulsion Medical Systems AG, a subsidiary of Getinge AB, is a medical device company that manufactures and develops critical care systems and monitors. The company’s products include ProAQT sensor, PiCCO catheter, CeVOX module, Pi …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Avadel Pharmaceuticals Plc (AVDL):医療機器:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • Tata Teleservices (Maharashtra) Ltd (TTML):企業の財務・戦略的SWOT分析
    Tata Teleservices (Maharashtra) Ltd (TTML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • GenMark Diagnostics Inc (GNMK):企業の製品パイプライン分析2018
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆